Search

Liver regeneration after partial hepatectomy (PH) is a complex and well-elaborated biological process whereby synchronized cell proliferation is induced in response to the loss of liver mass. Insulin-like growth factor 1 (IGF1) signaling, which plays a crucial role in normal growth and development, is involved in the process of liver regeneration. To assess the changes in the levels of serum IGF1 and hepatic IGF1 receptor (IGF1R), we established a mouse model for PH. This also allowed us to further explore the mechanisms that participate in the regulation of liver regeneration. Serum IGF1 dramatically decreased immediately after PH, and was mildly elevated afterwards. This was also confirmed in patients who had undergone PH. Immunohistochemistry and Western blotting showed that hepatic IGF1R expression was elevated after surgery in mice. Hepatosomatic index showed a mild elevation 1 week after surgery and a marked elevation after 3 weeks. Western blotting showed increased levels of forkhead box O3 (FOXO3), but the phosphorylated forms of v-akt murine thymoma viral oncogene homolog 1 (AKT1), glycogen synthase kinase 3 beta (GSK3B) and FOXO3 were all downregulated. Our data show that the GSK3B-FOXO3 pathway is activated after PH, and this may be one of the mechanisms that lead to upregulation of hepatic IGF1R after PH. All these changes after surgery promote liver regeneration.

Forty patients (25 cases of prostatic cancer and 15 cases of benign prostatic hyperplasia) were examined with radioimmunodetection (RAID) using antibody against r-Seminoprotein (r-Sm). The images of malignant tumor sites were revealed from the scan of single photon emission computerized tomography with the tracing of dual radionuclide and computer digital subtraction technique. Of the 25 patients with prostatic cancer tested, twenty-four were demonstrated in RAID with a positive rate of 96%. The ratio of taking in nuclide radioactivity between the tumor tissue and normal tissue (T/N) was 6.9 and the best showing time was the 96th hr from injection of radioactive antibody against r-Sm. The minimum diameter of the tumor detected in RAID was 0.5 cm. All of the 8 cases of metastatic prostatic cancer in pelvic or bone location were detected, with a rate of 100%. Of the 15 cases of benign prostatic hyperplasia, only one showed mild positive result. B-ultrasonography and CT showed a positive detective rate of 72.7% and 65%, respectively. Our results have indicated that RAID using 131I-labeled antibody against r-Sm possesses more advantages in specificity, because RAID not only defines the involved sites, but also shows the sites of the original tumors, and the metastatic location as well as the relationship between them.